Structural Genomics Consortium (SGC), Toronto, Canada
"Open drug discovery: From genes to affordable medicines"
Aled is the current and founding CEO of the Structural Genomics Consortium (SGC), a charity aiming to place information and reagents about human proteins into the public domain without restriction. The SGC focuses on under-studied proteins, including those that linked to human disease, including ALS/MND. Aled shall be speaking about this effort.